Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lucid Diagnostics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.942 -- 00:00:06.951 Good morning, and welcome to the Lucid Diagnostics First Quarter 2026 00:00:06.951 -- 00:00:12.619 Business Update Conference Call. Please note that this event is being recorded. 00:00:12.619 -- 00:00:17.807 I would now like to turn the conference over to Matt Riley, Lucid Diagnostics Vice 00:00:17.807 -- 00:00:22.353 President of Investor Relations. Please go ahead. 00:00:22.353 -- 00:00:24.416 Thank you, Operator, and good morning, everyone. 00:00:24.416 -- 00:00:27.335 Thank you for participating in today's Business Update Call. 00:00:27.335 -- 00:00:31.680 Joining me today on the call are Dr. Leshawn Acklog, Chairman and Chief Executive Officer 00:00:31.680 -- 00:00:37.526 of Lucid Diagnostics, along with Dennis McGrath, Chief Financial Officer of Lucid Diagnostics. 00:00:37.526 -- 00:00:40.910 The press release announcing our business update and financial results is available on 00:00:40.910 -- 00:00:42.852 Lucid's website. 00:00:42.852 -- 00:00:46.596 Please take a moment to read the disclaimers and forward-looking statements in the press 00:00:46.596 -- 00:00:51.001 release. The business update, press release, and the conference call all include forward-looking 00:00:51.001 -- 00:00:55.733 statements, and these forward-looking statements are subject to known and unknown risks 00:00:55.733 -- 00:00:59.539 and uncertainties that may cause actual results to differ materially from statements 00:00:59.539 -- 00:01:04.085 made. Factors that could cause actual results to differ are described in the disclaimer 00:01:04.085 -- 00:01:09.052 and in our filings with the SEC. For a list and a description of these and other important 00:01:09.052 -- 00:01:14.519 risks and uncertainties that may affect future operations, see Part 1, Item 1...